Cargando…

Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy

Detalles Bibliográficos
Autores principales:	Luchini, Claudio, Cheng, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673828/ https://www.ncbi.nlm.nih.gov/pubmed/29184801 http://dx.doi.org/10.21037/tau.2017.08.04

Ejemplares similares

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
por: Pan, Chin-Chen
Publicado: (2018)

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors
por: Lee, Kyoung-Hwa, et al.
Publicado: (2018)

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer—narrative review
por: Piszczek, Radosław, et al.
Publicado: (2020)

An MRI-based radiomics nomogram in predicting histologic grade of non-muscle-invasive bladder cancer
por: Li, Longchao, et al.
Publicado: (2023)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
por: Klaile, Yvonne, et al.
Publicado: (2016)

Improving outcome and prognosis prediction in non-muscle invasive bladder cancer using a gene expression score
por: Breyer, Johannes
Publicado: (2017)

Prediction of progression to muscle-invasive disease in patients with high-risk bladder cancer
por: Oszczudlowski, Maciej, et al.
Publicado: (2018)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

The optimal management of variant histology in muscle invasive bladder cancer
por: Tiwari, Raj Vikesh, et al.
Publicado: (2020)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
por: Jeong, Seung-hwan, et al.
Publicado: (2023)

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer
por: Ajib, Khaled, et al.
Publicado: (2018)

Urinary biomarker for the detection of recurrence following non-muscle invasive bladder cancer: are we there yet?
por: Tan, Wei Shen, et al.
Publicado: (2018)

A single immediate instillation of chemotherapy for non-muscle invasive bladder cancer: in all patients?
por: Sylvester, Richard
Publicado: (2018)

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer
por: Batura, Deepak
Publicado: (2018)

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
por: Hurst, Carolyn D., et al.
Publicado: (2021)

Next-generation sequencing in non-muscle-invasive bladder cancer—a step towards personalized medicine for a superficial bladder tumor
por: Butterfield, Andrew, et al.
Publicado: (2017)

Clinical benefit to regionalization of care for muscle invasive bladder cancer
por: Haque, Waqar, et al.
Publicado: (2018)

Taxonomy
por: McCann, Shaun R.
Publicado: (2020)

Editorial on the value of an immediate intravesical instillation of mitomycin C in patients with non-muscle-invasive bladder cancer
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Spinal anesthesia is associated with lower recurrence rates after resection of non-muscle invasive bladder cancer
por: Kweon, Tae Dong, et al.
Publicado: (2018)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer
por: Li, Deng-xiong, et al.
Publicado: (2021)

Age does not matter: the relevance of immediate instillation therapy with Mitomycin C in non-muscle invasive bladder cancer
por: Christoph, Frank, et al.
Publicado: (2018)

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer
por: Peyton, Charles C., et al.
Publicado: (2018)

Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology
por: Gkountakos, Anastasios, et al.
Publicado: (2022)

Taxonomy of quantities
por: Fuentes-Arderiu, Xavier
Publicado: (2012)

Identification of a gene signature for the prediction of recurrence and progression in non-muscle-invasive bladder cancer
por: Dalla, Emiliano, et al.
Publicado: (2022)

Bladder outlet obstruction and non-invasive urodynamics - The future?
por: Kekre, Nitin S.
Publicado: (2009)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers
por: Oosterlinck, Willem, et al.
Publicado: (2018)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Taxonomy is the cornerstone of biodiversity conservation-SEABRI reports on biological surveys in Southeast Asia
por: Li, Shu-Qiang, et al.
Publicado: (2017)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle invasive bladder cancer
por: Murphy, Neal, et al.
Publicado: (2022)

Molecular Subtyping in Muscle-Invasive Bladder Cancer on Predicting Survival and Response of Treatment
por: Bejrananda, Tanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lej1g5uukpf3c4jfmvmkhe7drp